Cancer Research Landon Prizes for Basic and Translational Cancer Research  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 57, 1722-1730, May 1, 1997]
© 1997 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ridet, A.
Right arrow Articles by Rosselli, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ridet, A.
Right arrow Articles by Rosselli, F.

Deregulated Apoptosis Is a Hallmark of the Fanconi Anemia Syndrome1

Agnès Ridet, Christel Guillouf, Eric Duchaud, Enrico Cundari, Mario Fiore, Ethel Moustacchi and Filippo Rosselli2

UMR218 du Centre National de la Recherche Scientifique, Institut Curie, Section de Recherche, LRC no. 1 du CEA, 26 rue d'Ulm, 75248 Paris Cedex 05, France [A. R., C. G., E. D., E. M., F. R.], and Consiglio Nazionale delle Ricerche, Centro Genetica Evoluzionistica, Rome, Italy [E. C., M. F.]

Fanconi anemia (FA) is a genetic human disorder associated with bone marrow failure and predisposition to cancer. FA cells show poor growth capacity and spontaneous chromosomal anomalies as well as cellular and chromosomal hypersensitivity to DNA cross-linking agents such as mitomycin C (MMC). Because it is likely that disruption of the apoptotic control would lead to such a phenotype, we investigated the implication of apoptosis in the FA syndrome. It is shown that, although demonstrating a high frequency of spontaneous apoptosis, FA cells from four genetic complementation groups are deficient in {gamma}-ray-induced apoptosis and their MMC hypersensitivity is not due to apoptosis. Fas is a cell surface receptor belonging to the tumor necrosis factor receptor family and is involved in apoptosis. We show that, independently of DNA damage, the alteration in the control of apoptosis in FA concerns also the pathway initiated by Fas activation. Finally, ectopic expression of the wild-type FAC gene corrects the MMC hypersensitivity and anomalies in apoptosis and cell cycle response in FA cells. Altogether, these findings strongly implicate the FA genes as playing a major role in the control of apoptosis. Thus, further studies with FA syndrome will be instrumental toward molecularly dissecting the apoptotic pathways.

1 This work was supported by EEC European Community (Brussels, Belgium), Association pour la Recherche sur le Cancer (Paris, France), Ligue Nationale contre le Cancer (Paris, France), Electricité de France (Paris, France), and Commissariat pour l'Energie Atomique (Paris, France).

2 To whom requests for reprints should be addressed. Phone: 33-142346708; Fax: 33-146333016; E-mail: rosselli@curie.fr.

Received 10/ 7/96. Accepted 3/ 1/97.




This article has been cited by other articles:


Home page
BloodHome page
J. Mi and G. M. Kupfer
The Fanconi anemia core complex associates with chromatin during S phase
Blood, January 15, 2005; 105(2): 759 - 766.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. Qiao, J. Mi, J. B. Wilson, G. Zhi, N. R. Bucheimer, N. J. Jones, and G. M. Kupfer
Phosphorylation of Fanconi Anemia (FA) Complementation Group G Protein, FANCG, at Serine 7 Is Important for Function of the FA Pathway
J. Biol. Chem., October 29, 2004; 279(44): 46035 - 46045.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Thomashevski, A. A. High, M. Drozd, J. Shabanowitz, D. F. Hunt, P. A. Grant, and G. M. Kupfer
The Fanconi Anemia Core Complex Forms Four Complexes of Different Sizes in Different Subcellular Compartments
J. Biol. Chem., June 18, 2004; 279(25): 26201 - 26209.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
M D Tischkowitz and S V Hodgson
Fanconi anaemia
J. Med. Genet., January 1, 2003; 40(1): 1 - 10.
[Abstract] [Full Text]


Home page
MutagenesisHome page
M. Bogliolo, O. Cabre, E. Callen, V. Castillo, A. Creus, R. Marcos, and J. Surralles
The Fanconi anaemia genome stability and tumour suppressor network
Mutagenesis, November 1, 2002; 17(6): 529 - 538.
[Abstract] [Full Text] [PDF]


Home page
MutagenesisHome page
M. Bogliolo, S. Borghini, A. Abbondandolo, and P. Degan
Alternative metabolic pathways for energy supply and resistance to apoptosis in Fanconi anaemia
Mutagenesis, January 1, 2002; 17(1): 25 - 30.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Y. Dror and M. H. Freedman
Shwachman-Diamond syndrome marrow cells show abnormally increased apoptosis mediated through the Fas pathway
Blood, May 15, 2001; 97(10): 3011 - 3016.
[Abstract] [Full Text] [PDF]


Home page
MutagenesisHome page
A. Zunino, P. Degan, T. Vigo, and A. Abbondandolo
Hydrogen peroxide: effects on DNA, chromosomes, cell cycle and apoptosis induction in Fanconi's anemia cell lines
Mutagenesis, May 1, 2001; 16(3): 283 - 288.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
D. W. Brois, L. W. McMahon, N. I. Ramos, L. M. Anglin, C. E. Walsh, and M. W. Lambert
A deficiency in a 230 kDa DNA repair protein in Fanconi anemia complementation group A cells is corrected by the FANCA cDNA
Carcinogenesis, September 1, 1999; 20(9): 1845 - 1853.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
I. Garcia-Higuera, Y. Kuang, D. Naf, J. Wasik, and A. D. D'Andrea
Fanconi Anemia Proteins FANCA, FANCC, and FANCG/XRCC9 Interact in a Functional Nuclear Complex
Mol. Cell. Biol., July 1, 1999; 19(7): 4866 - 4873.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
T. Yamashita, G. M. Kupfer, D. Naf, A. Suliman, H. Joenje, S. Asano, and A. D. D'Andrea
The Fanconi anemia pathway requires FAA phosphorylation and FAA/FAC nuclear accumulation
PNAS, October 27, 1998; 95(22): 13085 - 13090.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
D. Näf, G. M. Kupfer, A. Suliman, K. Lambert, and A. D. D'Andrea
Functional Activity of the Fanconi Anemia Protein FAA Requires FAC Binding and Nuclear Localization
Mol. Cell. Biol., October 1, 1998; 18(10): 5952 - 5960.
[Abstract] [Full Text]


Home page
BloodHome page
L. S. Haneline, H. E. Broxmeyer, S. Cooper, G. Hangoc, M. Carreau, M. Buchwald, and D. W. Clapp
Multiple Inhibitory Cytokines Induce Deregulated Progenitor Growth and Apoptosis in Hematopoietic Cells From Fac-/- Mice
Blood, June 1, 1998; 91(11): 4092 - 4098.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Carreau, O. I. Gan, L. Liu, M. Doedens, C. McKerlie, J. E. Dick, and M. Buchwald
Bone Marrow Failure in the Fanconi Anemia Group C Mouse Model After DNA Damage
Blood, April 15, 1998; 91(8): 2737 - 2744.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. Qiao, A. Moss, and G. M. Kupfer
Fanconi Anemia Proteins Localize to Chromatin and the Nuclear Matrix in a DNA Damage- and Cell Cycle-regulated Manner
J. Biol. Chem., June 22, 2001; 276(26): 23391 - 23396.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1997 by the American Association for Cancer Research.